The chief focus of this week’s meetings – I like to try and make decent clusters from my travelogue – was Industrial Biotechnology in various guises, not least since Bioenergy and Industrial Biotechnology are a key element of our Strategic Plan.

We had an important and useful meeting with the Technology Strategy Board, with whom we enjoy an increasingly close and integrated relationship (including a shared employee). Grants are in the throes of being judged and awarded as part of the Sustainable Agriculture and Food Innovation Platform, while there are other Healthcare activities in Regenerative and in Personalised Medicine. [...]